Phase I trial of ABT 354
Latest Information Update: 26 Oct 2011
At a glance
- Drugs SLV 354 (Primary)
- Indications Alzheimer's disease; Neurological disorders
- Focus Adverse reactions
- Sponsors Abbott Laboratories
- 26 Oct 2011 New trial record
Latest Information Update: 26 Oct 2011